Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the mfn-opts domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6131
Thomas, Alito Blast SCOTUS For Helping ‘Undermine’ Dobbs With Abortion Drug Ruling, by Shawn Fleetwood – Brown Pelican Society of Lousiana

Thomas, Alito Blast SCOTUS For Helping ‘Undermine’ Dobbs With Abortion Drug Ruling, by Shawn Fleetwood

Supreme Court Continues to Allow Abortion Pill to Be Dispensed Through Mail, by Nancy Flanders
May 15, 2026
Fr. Jerry J. Pokorsky: Do Good, Avoid Evil
May 15, 2026

Image Credit. Mathieu Landretti. Wikimedia Commons/CC BY-SA 4.0

By Shawn Fleetwood, The Federalist, May 14, 2026

Shawn Fleetwood is a staff writer for The Federalist and a graduate of the University of Mary Washington. …

‘Louisiana’s [pro-life] efforts have been thwarted by certain medical providers, private organizations, and States that abhor laws like Louisiana’s and seek to undermine their enforcement,’ wrote Justice Alito.

Author Shawn Fleetwood profileJustices Clarence Thomas and Samuel Alito had some choice words for their Supreme Court colleagues on Thursday over their “remarkable” decision “undermin[ing]” the court’s historic Dobbs decision overturning Roe v. Wade.

The stinging rebukes came in an order the high court handed down to temporarily pause an appellate court ruling that halted a Biden-era FDA rule allowing the mailing of mifepristone to women without an in-person doctor visit. In agreeing to halt the policy, the 5th Circuit Court of Appeals found that the FDA’s “progressive relaxation of mifepristone’s guardrails likely lacked a basis in data and scientific literature,” and noted how the “FDA itself now concedes the regulations were marred by ‘procedural deficits’ and a ‘lack of adequate consideration.’” …

Continue reading >>>>>>>>>>